Immunoassay Market
Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Analyzers), by Technology (Immunoassay/Immunochemistry, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting), by Specimen (Blood, Saliva, Urine, Other Specimens), by Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders), by End User (Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies & CROs, Blood Banks), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
Market Snapshot
| Forecast Years for Immunoassay Market: | 2022 - 2028 |
| Historical Years for Immunoassay Market: | 2016 - 2021 |
| Revenue 2021 for Immunoassay Market: | 27,694.60 USD Million |
| Revenue 2028 for Immunoassay: | 40,183.23 USD Million |
| Revenue CAGR (2022 - 2028) for Immunoassay Market : | 6.40% |
| Fastest Growing Region (2022 - 2028) for Immunoassay Market: | Asia Pacific |
| Largest Region (2021) for Immunoassay Market: | North America |
Immunoassay Market
Market Synopsys:
The growth in the adoption of Immunoassay products and the advanced technology introduced in Immunoassay are the major factors expected to drive the demand for Immunoassay in the upcoming years. Moreover, the technological advancements which increase the efficiency of Immunoassay in terms of performance and cost, like the design of immunochemical which is projecting growth of Immunoassay market in upcoming years. The growth of the global Immunoassay market is mainly attributed to the rising incidence of infectious and chronic diseases during the forecast period. Additionally, the increasing number of geriatric populations across the world, growth in the pharmaceutical and biotechnology sector, and a high degree of accuracy of Immunoassay are the other major factors driving the growth of the Immunoassay market during the forecast period. The incidence of cancer is increasing day-by-day which is projected to drive the demand for effective diagnostic methods like Immunoassay which is boosting the growth of the Immunoassay market during the forecast period. Various evolving technologies like condition-specific biomarkers among various others are expected to increase the demand for Immunoassay in the years to come. The occurrence of coronavirus has led to the manufacturing of rapid diagnostic tests which use Immunoassay techniques which are expected to drive the Immunoassay compounds and devices market in the upcoming years.
Market Segmentation:
The Immunoassay market is sub-divided on the basis of Product, Technology, Specimen, Application, and End-user. On the basis of Product, the market is segmented as Reagents & Kits, and Analyzers. On the basis of Technology, the market is segmented as Immunoassay/Immunochemistry, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Radio-Immuno Assay, and Other Technologies. By Specimen, the market is segmented as Blood, Saliva, Urine, and Other Specimens. On the basis of Application, the market is segmented as Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Diagnostics, Toxicology, Newborn Screening, and Other Applications. On the basis of end-user, the market is segmented as Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies & CROs, Blood Banks, Research & Academic Laboratories, and Home Care Settings.
Below tree is interactive. You can click the nodes to get more information.
The infectious disease segment holds the largest revenue share
In 2021, the infectious disease segment holds the largest revenue in the market and this high share is attributed to growth in the incidence of infectious diseases like malaria, HIV, influenza, and coronavirus. The launch of innovative and new products in infectious disease testing is driving the growth of the Immunoassay market in the upcoming years. According to the new research published by International Agency for Research on Cancer, the cancer incidence was projected to be 18 million new cases, whereas about 9.6 million deaths due to disease, and this rise in the incidence of cancer is estimated to boost the adoption of Immunoassay in the years to come.
The Hospital sector acquires the largest market share during the forecast period
The increasing number of hospitals has led to the highest growth of the hospital segment in the end-user sector of the Immunoassay market in the upcoming years. With the ongoing changes in the healthcare industry, the demand for hospitals along with advanced facilities has increased which is expected to drive the demand for hospitals in the Immunoassay market during the forecast period. Moreover, blood banks are anticipated to demonstrate the highest growth during the forecast period due to the rise in the number of infectious diseases being tested in the laboratories during the processing of donated blood.
North America holds the largest share of the Immunoassay market during the forecast period
In 2021, North America acquires the largest market share during the forecast period and this dominance is allocated to rising demand for diagnostics owing to the increase in the incidence of cancer and the effortless availability of technically advanced diagnostic techniques. Additionally, growth in infectious diseases like tuberculosis and influenza is boosting the demand for detection and treatment in the Immunoassay market in North America.
Besides, the Asia Pacific region is estimated to witness lucrative growth in the Immunoassay market during the forecast period. This is ascribed to growing cancer patients and increased investments in the healthcare sector. Moreover, the growing public private partnerships to enhance the healthcare sector in the region is further estimated to enhance the market growth during the forecast period.
Competitive Landscape:
The prime key players in the Immunoassay market are applying various innovative strategies for the growth of the Immunoassay market in the coming years. Some of the major key players in the Immunoassay market are Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Roche (Switzerland), Siemens Healthineer (Germany), Quidel (US), DiaSorin (Italy), bioMérieux (France), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), PerkinElmer (US) Becton, Dickinson & Company (US), Sysmex (Japan), Agilent Technologies (US), Mindray (China), QIAGEN (Netherlands), Merk KGaA (Germany), Bio-Techne (US), Cellabs (Australia), Abnova Corporation (Taiwan), J. Mitra & Co. Pvt. Ltd. (India), Tosoh Corporation (Japan), Cell Sciences (US), Enzo Biochem, Inc.(US), Creative Diagnostics (US), Boster Biological Technology (US), Elabscience, Inc (US), WAK-Chemie Medical GmbH (Germany), Sera Care (US), Epitope Diagnostics Inc. (US), Kamiya Biomedical Company (US) and Gyros Protein Technologies (Sweden).
Immunoassay Market is segmented as follows:
Parameter
Details
Segments Covered
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Immunoassay Market is tabulated as follows:
Frequently Asked Questions
-
What is
the global demand for Immunoassay
in terms of revenue?
The global Immunoassay valued at 27,694.60 USD Million in 2020 and is expected to reach 40,183.23 USD Million in 2028 growing at a CAGR of 6.40%
-
Which
are the prominent players
in the market?
The prominent players in the market are Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US), Roche (Switzerland), Siemens Healthineer (Germany), Quidel (US), DiaSorin (Italy), bioMérieux (France), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), PerkinElmer (US) Becton, Dickinson & Company (US), Sysmex (Japan), Agilent Technologies (US), Mindray (China), QIAGEN (Netherlands), Merk KGaA (Germany), Bio-Techne (US), Cellabs (Australia), Abnova Corporation (Taiwan), J. Mitra & Co. Pvt. Ltd. (India), Tosoh Corporation (Japan), Cell Sciences (US), Enzo Biochem, Inc.(US), Creative Diagnostics (US), Boster Biological Technology (US), Elabscience, Inc (US), WAK-Chemie Medical GmbH (Germany), Sera Care (US), Epitope Diagnostics Inc. (US), Kamiya Biomedical Company (US) and Gyros Protein Technologies (Sweden).
-
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 6.40% between 2021 and 2028.
-
What are
the driving factors
fueling the growth of the market.
The driving factors of the Immunoassay include
- introduction of advanced technology
-
Which
region accounted for the
largest share in the market?
North America was the leading regional segment of the Immunoassay in 2020.
Choose License
Our Companies
